Adam S Grossman is President and CEO of ADMA BIOLOGICS, INC.. Currently has a direct ownership of 2.06 Million shares of ADMA, which is worth approximately $41.8 Million. The most recent transaction as insider was on Mar 19, 2025, when has been sold 21,000 shares (Common Stock) at a price of $18.92 per share, resulting in proceeds of $397,320. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.06M
3.66% 3M change
22.87% 12M change
Total Value Held $41.8 Million

Adam S Grossman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 19 2025
SELL
Open market or private sale
$397,320 $18.92 p/Share
21,000 Reduced 1.01%
2,061,850 Common Stock
Mar 19 2025
BUY
Exercise of conversion of derivative security
$81,000 $5.4 p/Share
15,000 Added 0.72%
2,082,850 Common Stock
Mar 07 2025
SELL
Payment of exercise price or tax liability
$502,311 $17.02 p/Share
29,513 Reduced 1.41%
2,067,850 Common Stock
Mar 06 2025
SELL
Payment of exercise price or tax liability
$954,366 $16.91 p/Share
56,438 Reduced 2.62%
2,097,363 Common Stock
Feb 26 2025
SELL
Payment of exercise price or tax liability
$865,801 $15.78 p/Share
54,867 Reduced 2.48%
2,153,801 Common Stock
Feb 25 2025
SELL
Payment of exercise price or tax liability
$278,197 $15.44 p/Share
18,018 Reduced 0.81%
2,208,668 Common Stock
Feb 19 2025
BUY
Grant, award, or other acquisition
-
252,022 Added 10.17%
2,226,686 Common Stock
Dec 31 2024
SELL
Payment of exercise price or tax liability
$245,982 $17.15 p/Share
14,343 Reduced 0.72%
1,974,664 Common Stock
Nov 22 2024
SELL
Open market or private sale
$1,033,203 $21.1 p/Share
48,967 Reduced 2.4%
1,989,007 Common Stock
Sep 30 2024
SELL
Payment of exercise price or tax liability
$434,822 $19.99 p/Share
21,752 Reduced 1.06%
2,037,974 Common Stock
Aug 27 2024
SELL
Open market or private sale
$6,731,965 $17.29 p/Share
389,356 Reduced 15.9%
2,059,726 Common Stock
Aug 27 2024
BUY
Exercise of conversion of derivative security
$1,222,577 $3.14 p/Share
389,356 Added 13.72%
2,449,082 Common Stock
Aug 26 2024
SELL
Open market or private sale
$4,190,566 $17.69 p/Share
236,889 Reduced 10.31%
2,059,726 Common Stock
Aug 26 2024
BUY
Exercise of conversion of derivative security
$1,634,534 $6.9 p/Share
236,889 Added 9.35%
2,296,615 Common Stock
Jun 30 2024
SELL
Payment of exercise price or tax liability
$243,187 $11.18 p/Share
21,752 Reduced 1.05%
2,059,726 Common Stock
Jun 14 2024
SELL
Open market or private sale
$1,072,000 $10.72 p/Share
100,000 Reduced 4.58%
2,081,475 Common Stock
Jun 14 2024
SELL
Bona fide gift
-
10,000 Reduced 0.46%
2,181,475 Common Stock
Jun 14 2024
SELL
Other acquisition or disposition
$1,476,600 $3.21 p/Share
460,000 Reduced 17.35%
2,191,475 Common Stock
Mar 31 2024
SELL
Payment of exercise price or tax liability
$143,563 $6.6 p/Share
21,752 Reduced 0.81%
2,651,475 Common Stock
Mar 07 2024
SELL
Payment of exercise price or tax liability
$177,180 $6.16 p/Share
28,763 Reduced 1.06%
2,673,227 Common Stock
Mar 06 2024
SELL
Payment of exercise price or tax liability
$336,618 $6.12 p/Share
55,003 Reduced 2.0%
2,701,990 Common Stock
Feb 29 2024
SELL
Payment of exercise price or tax liability
$51,391 $5.36 p/Share
9,588 Reduced 0.35%
2,756,993 Common Stock
Feb 26 2024
BUY
Grant, award, or other acquisition
-
557,728 Added 16.78%
2,766,581 Common Stock
Feb 25 2024
SELL
Payment of exercise price or tax liability
$118,123 $5.26 p/Share
22,457 Reduced 1.01%
2,208,853 Common Stock
Dec 31 2023
SELL
Payment of exercise price or tax liability
$104,217 $4.52 p/Share
23,057 Reduced 1.02%
2,231,310 Common Stock
ASG

Adam S Grossman

President and CEO
Ramsey, NJ

Track Institutional and Insider Activities on ADMA

Follow ADMA BIOLOGICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADMA shares.

Notify only if

Insider Trading

Get notified when an Adma Biologics, Inc. insider buys or sells ADMA shares.

Notify only if

News

Receive news related to ADMA BIOLOGICS, INC.

Track Activities on ADMA